Email Contact Phone Company Visit Website

SimCorp A/S Office Head Office

Weidekampsgade 16
Copenhagen S

SimCorp Germany Office

Justus-von-Liebig-Straße 1
Bad Homburg

SimCorp Norway Office

Biskop Gunnerusgade 14 A


+45 35446416 Mobile +45 6127 6137


Peter Tranberg
[email protected]
Back to all SimCorp announcements

Exane Selects SimCorp Dimension

SimCorp, a leading provider of investment management solutions and services for the global financial services industry, today announced that Exane has selected SimCorp Dimension to support its middle and back-office operations for listed and OTC derivatives. Based in Paris, Exane is an independent investment firm with three main lines of business (Brokerage in Cash Equities, Derivatives, and Asset Management), which services a diversified European and global client base. 

In an increasingly competitive environment, Exane decided to replace a technology platform consisting of a number of different systems with one single integrated solution. After a rigorous selection process including a thorough Proof of Concept, SimCorp Dimension stood out as the solution best suited to support Exane’s current and future business needs and strategy.

Benoît Catherine, Deputy CEO, commented: “We have selected SimCorp Dimension for its extensive functional scope, especially in the derivatives area, as well as its proven ability to automate middle and back-office processes. The implementation of SimCorp Dimension will enable us to scale for growth while improving our post trade processes. The first phase of the project will start in June 2016 and is expected to be extended to other business lines in the future.”

Emmanuel Colson, Managing Director at SimCorp France, commented: “We are very pleased to welcome Exane in our growing community of French and international clients. Exane is a key player in the European derivatives space and their choice of SimCorp Dimension is a tribute to the system’s ability to support and ease our clients growth by removing operational complexity and the associated risk.”